Atherectomy Systems Market
Number of pages: 100 | Report Format: PDF | Published date: April 18, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023-2031
|
Report Attribute |
Details |
|
Market Size Value in 2022 |
US$ 696.1 Million |
|
Market Size Value in 2031 |
US$ 1,143.1 Million |
|
CAGR |
7.1% |
|
Base Year For Estimation |
2022 |
|
Forecast Period |
2023 to 2031 |
|
Historical Year |
2021 |
|
Segments Covered |
Type, Application, End User, and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the global atherectomy systems market was valued at US$ 696.1 million in 2022 and is expected to register a revenue CAGR of 7.1% to reach US$ 1,143.1 million by 2031.
Atherectomy Systems Market Fundamentals
Atherectomy is a local anesthetic-assisted endovascular minimally invasive surgical treatment. Atherectomy is frequently performed as an alternative to conventional open surgery to improve blood flow and lower the risk of heart attack or stroke. Compared to more invasive operations, the procedure is typically well-tolerated and has a relatively short recovery period. Atherectomy removes plaque and hardened lesions from the artery to create a substantial lumen, which aids in reviving blood flow in the arteries. They are frequently employed in peripheral, neurovascular, and cardiovascular applications. Even though there is still more research on these systems, atherectomy systems have already been shown to be a vital component of minimally invasive treatments for cardiovascular disease. Other medical disciplines, such as treating peripheral artery disease and stroke, also use these systems. It often uses catheter-based techniques, including direct aspiration, stent extraction, or combining the two. The potential of these atherectomy systems to treat other diseases like deep vein atherosclerosis and pulmonary embolism is also being explored by continuing research.
[22]
Atherectomy Systems Market Dynamics
The increasing incidence of atherosclerosis is the key driver of the global atherectomy systems market revenue. Globally, the prevalence of increased carotid intima-media thickness, i.e., atherosclerosis, is predicted to be 27.62% in people aged 30-79 in 2020, which equates to 1,066.70 million cases, carotid plaque prevalence to be 21.13%, which equates to 815.76 million patients, and carotid stenosis prevalence to be 1.5%, which equates to 57.79 million cases. This rising prevalence of atherosclerosis leads to increased minimally invasive procedures, such as atherectomy, to remove plaque buildup in arteries. The development of advanced atherectomy systems and increasing demand for minimally invasive procedures are expected to drive the growth of the global atherectomy systems market.
Owing to the rise in chronic diseases, the demand for less intrusive solutions, technological advancements, user-friendliness, and market entrants, the global atherectomy systems market revenue growth is expected to remain rapid during the forecast period. The world's growing geriatric population, alterations in lifestyle, and genetic anomalies within the population base all contribute to atherosclerosis, providing the industry with room to grow significantly. The market for atherosclerosis systems is expected to grow rapidly during the forecast period due to rising illness awareness and the availability of cutting-edge diagnostic and therapeutic alternatives. Government programs to support early detection and treatment are also expected to fuel market revenue acceleration. Governments and industries from different countries are taking initiatives to promote atherectomy procedures to irradiate complete heart blockage. For instance, in March 2021, the National Institute of Health published an article to describe physician practice patterns and examine physician-level factors associated with the use of atherectomy during index revascularization for patients with femoropopliteal peripheral artery disease.
Adopting cutting-edge technologies is also expected to drive the market for the atherectomy systems market. Laser and UV radiation development, recombinant technologies, and 3D picture generation are a few examples. Atherectomy systems also have several benefits, including low risk of complications, no vessel wall damage, effectiveness in rebuilding vessel patency, ability to uncover a fundamental abscess, targeted treatment, lack of need for lysis drug and vessel preparation, short hospital stay, lack of demand for intensive care unit stay, ease of use, and affordability. These elements are the only ones that help the global market revenue grow more quickly and profitably.
However, the development of the market is hampered by challenges such as ineffective atherectomy in angled and sclerotic aortic bifurcations, the risk of vessel wall breakdown and rupture in highly calcified vessels, high costs for catheter systems, the potential for distal embolization within atherectomy indications, the absence of a catheter device for below-the-knee atherectomy, and a minimal lumen vessel of 4 mm. Despite the difficulties the industry faces, researchers and medical experts are actively working to create creative solutions to deal with these problems and enhance patient results. During the forecast period, thrombectomy is expected to continue to develop and grow due to ongoing advances in technology and medical research.
Atherectomy Systems Market Ecosystem
The global atherectomy systems market is analyzed from four perspectives: type, application, end-user, and region.
Atherectomy Systems Market by Type
[302]
Based on types, the global atherectomy systems market is segmented as orbital, directional, rotational, and photo-ablative (laser).
The rotational atherectomy systems segment accounted for the largest revenue share of the global atherectomy systems market in 2022. Using rotating atherectomy systems has several significant benefits contributing to the segment's revenue growth. Rotational atherectomy is the most secure procedure when the arteries are severely calcified or blocked. The development of rotating atherectomy and thrombectomy devices has transformed how doctors treat cardiovascular disorders. By utilizing a spinning burr or blade, these devices use rotational forces to clear obstructions in the arteries, allowing blood to flow more freely. This has been demonstrated to be a safe and efficient treatment for peripheral arterial disease, coronary artery disease, and other cardiovascular disorders. This contributed to the overall segment's revenue share.
Additionally, a rotating atherectomy system can enhance balloon angioplasty outcomes and lower restenosis rates. Rotational atherectomy of ostial lesions improves clinical and procedural developments in contrast to balloon angioplasty, and it requires less side-branch intervention. In these ostial lesions, combining rotational devices with stenting resulted in lower restenosis rates than stenting alone. It has also been proposed as a first-line remedy for unhealing abrasions containing fibrocalcific plaque. For this type of tumor, reported rotational treatments were successful in more than 90% of cases. In conclusion, the rotational type is significant in the interventional toolbox for treating challenging and heavily calcified lesions since it expedites and simplifies the procedure without compromising restenosis or long-term clinical results.
Atherectomy Systems Market by Application
Based on the application, the global atherectomy systems market is segmented into cardiovascular diseases, peripheral artery diseases, and neurovascular diseases.
The peripheral artery diseases segment accounted for the largest revenue share of the global atherectomy systems market in 2022. Narrowed arteries in peripheral artery disease, a common cardiovascular condition, restrict blood flow to the limbs, most frequently the legs. By removing plaque buildup in the arteries, atherectomy systems improve blood flow and lessen symptoms like discomfort and cramps. The rising incidence of peripheral arterial disease is just one of the factors contributing to the segment's dominance in the atherectomy systems market in terms of revenue share. Around 6.5 million Americans aged 40 and older have peripheral artery disease. According to researchers, more than 190,000 atherectomies are carried out by medical professionals annually in the United States. Atherectomy systems also benefit over conventional peripheral artery disease therapies like angioplasty and stenting. Atherectomy methods can also prevent restenosis or the re-narrowing of the treated artery and retain healthy arterial tissue.
Atherectomy Systems Market by End User
Based on the end user, the global atherectomy systems market is segmented into hospitals, ambulatory surgery centers, and others.
The hospital's segment accounted for the largest global atherectomy systems market revenue share in 2022. As they have more operating capital to invest in advanced medical technologies, hospitals have influenced the global atherectomy systems market outlook. Because they are characteristically multi-specialty facilities, hospitals have the necessary medical equipment to provide patients with comprehensive care. In addition, hospitals have a larger workforce of doctors, nurses, and other healthcare workers who may offer patients specialized care. Hospitals are the best option for individuals needing complicated medical procedures and treatments. The rising prevalence of chronic vascular diseases, expanding access to healthcare reimbursements in many developed countries, growing use of atherectomy for the amelioration of peripheral and cardiac vascular conditions present technological advancements in the field of minimally invasive or image-guided atherectomy procedures, and more are all factors that contribute to this segment's sizable market revenue share. The hospital sector dominated the global market due to rising awareness of the many advantages of this procedure, including less blood loss during surgery, a lower risk of complications from internal organ compression or friction caused by atherosclerosis plaque formation around the vessels, and the accessibility of atherectomy equipment.
Atherectomy Systems Market by Region
Based on regions, the global atherectomy systems market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
North America accounted for the largest revenue share of the global atherectomy systems market in 2022. North America had the greatest percentage of the atherectomy systems market revenue due to important factors such as a growing geriatric population, a high level of disposable income, a sophisticated diagnostic system, a high frequency of lifestyle-related changes, and an increase in cardiovascular illnesses. Government initiatives to increase public awareness and sophisticated infrastructure greatly impact the market's revenue growth during the forecast period. Well-established healthcare facilities, generous reimbursement policies, and growing patient awareness also influence its significant revenue share.
Atherectomy Systems Competitive Landscape
Notable market participants holding the largest revenue share of the global atherectomy systems market include,
Atherectomy Systems Market Strategic Development
Atherectomy systems are catheter-based devices used to perform atherectomy, a procedure to remove plaques from blood vessels.
The increased prevalence of cardiovascular diseases, including stroke and heart blockage, is the major driving factor responsible for the steady revenue growth of the atherectomy systems market.
The disease remains untreated due to the lack of proper knowledge and awareness, which is one of the most important challenges for the atherectomy systems market revenue growth.
Key companies operating the global Atherectomy Systems market are Abbott Laboratories, B. Braun SE, Boston Scientific Corporation, Becton, Dickinson and Company, and Cardinal Health Inc.
The global atherectomy systems market is expected to grow at a revenue CAGR of 7.1% during the forecast period from 2023 to 2031.
*Insights on financial performance are subject to the availability of information in the public domain